Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Methylprednisolone × Clear all

NCT02962284 2021-11-19

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Phase 2 Completed

20 enrolled 12 charts

Prostatic Neoplasms